Literature DB >> 15858018

Compartmentalization of hepatitis C virus genotypes between plasma and peripheral blood mononuclear cells.

Anne-Marie Roque-Afonso1, Delphine Ducoulombier, Gaëtana Di Liberto, Rachid Kara, Michele Gigou, Elisabeth Dussaix, Didier Samuel, Cyrille Féray.   

Abstract

Differences in hepatitis C virus (HCV) variants of the highly conserved 5' untranslated region (UTR) have been observed between plasma and peripheral blood mononuclear cells (PBMC). The prevalence and the mechanisms of this compartmentalization are unknown. Plasma and PBMC HCV variants were compared by single-strand conformation polymorphism (SSCP) and by cloning or by genotyping with a line probe assay (LiPA) in 116 chronically infected patients, including 44 liver transplant recipients. SSCP patterns differed between compartments in 43/109 analyzable patients (39%). Differences were significantly more frequent in patients with transplants (21/38 [55%] versus 22/71 [31%]; P < 0.01) and in those who acquired HCV through multiple transfusions before 1991 (15/20; 75%) or through drug injection (16/31; 52%) than in those infected through an unknown route (7/29; 24%) or through a single transfusion (5/29; 17%; P < 0.001). Cloning of the 5' UTR, LiPA analysis, and nonstructural region 5B sequencing revealed different genotypes in the two compartments from 10 patients (9%). In nine patients, the genotype detected in PBMC was not detected in plasma and was weak or undetectable in the liver in three cases. This genotypic compartmentalization persisted for years in three patients and after liver transplantation in two. The present study shows that a significant proportion of HCV-infected subjects harbor in their PBMC highly divergent variants which were likely acquired through superinfections.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15858018      PMCID: PMC1091708          DOI: 10.1128/JVI.79.10.6349-6357.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection.

Authors:  C Bain; A Fatmi; F Zoulim; J P Zarski; C Trépo; G Inchauspé
Journal:  Gastroenterology       Date:  2001-02       Impact factor: 22.682

2.  Nucleotide and amino acid complexity of hepatitis C virus quasispecies in serum and liver.

Authors:  B Cabot; M Martell; J I Esteban; S Sauleda; T Otero; R Esteban; J Guàrdia; J Gómez
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  Release of virus from lymphoid tissue affects human immunodeficiency virus type 1 and hepatitis C virus kinetics in the blood.

Authors:  V Müller; A F Marée; R J De Boer
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

4.  Hepatitis C virus in lymphoid cells of patients coinfected with human immunodeficiency virus type 1: evidence of active replication in monocytes/macrophages and lymphocytes.

Authors:  T Laskus; M Radkowski; A Piasek; M Nowicki; A Horban; J Cianciara; J Rakela
Journal:  J Infect Dis       Date:  2000-02       Impact factor: 5.226

5.  Comparative analysis of translation efficiencies of hepatitis C virus 5' untranslated regions among intraindividual quasispecies present in chronic infection: opposite behaviors depending on cell type.

Authors:  J Laporte; I Malet; T Andrieu; V Thibault; J J Toulme; C Wychowski; J M Pawlotsky; J M Huraux; H Agut; A Cahour
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

6.  Cell type-specific enhancement of hepatitis C virus internal ribosome entry site-directed translation due to 5' nontranslated region substitutions selected during passage of virus in lymphoblastoid cells.

Authors:  H Lerat; Y K Shimizu; S M Lemon
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

7.  The origin of hepatitis C virus reinfecting transplanted livers: serum-derived versus peripheral blood mononuclear cell-derived virus.

Authors:  Tomasz Laskus; Marek Radkowski; Jeffrey Wilkinson; Hugo Vargas; Jorge Rakela
Journal:  J Infect Dis       Date:  2002-01-31       Impact factor: 5.226

8.  The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies.

Authors:  P Farci; A Shimoda; A Coiana; G Diaz; G Peddis; J C Melpolder; A Strazzera; D Y Chien; S J Munoz; A Balestrieri; R H Purcell; H J Alter
Journal:  Science       Date:  2000-04-14       Impact factor: 47.728

9.  The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes.

Authors:  A L Erickson; Y Kimura; S Igarashi; J Eichelberger; M Houghton; J Sidney; D McKinney; A Sette; A L Hughes; C M Walker
Journal:  Immunity       Date:  2001-12       Impact factor: 31.745

10.  Exposure of hepatitis C virus (HCV) RNA-positive recipients to HCV RNA-positive blood donors results in rapid predominance of a single donor strain and exclusion and/or suppression of the recipient strain.

Authors:  T Laskus; L F Wang; M Radkowski; H Vargas; M Nowicki; J Wilkinson; J Rakela
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

View more
  47 in total

1.  The hepatitis C virus 5'UTR genomic region remains highly conserved under HAART: a 4- to 8-year longitudinal study from HCV/HIV co-infected patients.

Authors:  Franco Moretti; Federico Bolcic; Lilia Mammana; Maria Belen Bouzas; Natalia Laufer; Jorge Quarleri
Journal:  AIDS Res Hum Retroviruses       Date:  2010-05       Impact factor: 2.205

2.  Expression of microRNA miR-122 facilitates an efficient replication in nonhepatic cells upon infection with hepatitis C virus.

Authors:  Takasuke Fukuhara; Hiroto Kambara; Mai Shiokawa; Chikako Ono; Hiroshi Katoh; Eiji Morita; Daisuke Okuzaki; Yoshihiko Maehara; Kazuhiko Koike; Yoshiharu Matsuura
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

Review 3.  Mechanisms of HCV survival in the host.

Authors:  Ella H Sklan; Prista Charuworn; Philip S Pang; Jeffrey S Glenn
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-04       Impact factor: 46.802

4.  Ultradeep pyrosequencing of NS3 to predict response to triple therapy with protease inhibitors in previously treated chronic hepatitis C patients.

Authors:  Sylvie Larrat; Om Kulkarni; Jean-Baptiste Claude; Réjane Beugnot; Michaël G B Blum; Katia Fusillier; Julien Lupo; Pauline Tremeaux; Agnès Plages; Alice Marlu; Hervé Duborjal; Anne Signori-Schmuck; Olivier Francois; Jean-Pierre Zarski; Patrice Morand; Vincent Leroy
Journal:  J Clin Microbiol       Date:  2014-11-19       Impact factor: 5.948

5.  Human Interferon Regulatory Factor 2 Gene Expression is Induced in Chronic Hepatitis C Virus Infection-A Possible Mode of Viral Persistence.

Authors:  Rathindra M Mukherjee; Budhapriyavilas Bansode; Puja Gangwal; Aparna Jakkampudi; Panyala B Reddy; Padaki N Rao; Rajesh Gupta; D Nageshwar Reddy
Journal:  J Clin Exp Hepatol       Date:  2012-04-12

6.  Compartmentalization of hepatitis B virus: Looking beyond the liver.

Authors:  Sibnarayan Datta
Journal:  World J Hepatol       Date:  2015-09-18

7.  Analysis of the 5'UTR of HCV genotype 3 grown in vitro in human B cells, T cells, and macrophages.

Authors:  Dennis Revie; Michael O Alberti; John G Prichard; Ann S Kelley; S Zaki Salahuddin
Journal:  Virol J       Date:  2010-07-13       Impact factor: 4.099

8.  Compartmentalization of hepatitis C virus (HCV) during HCV/HIV coinfection.

Authors:  Jason T Blackard; Yoichi Hiasa; Laura Smeaton; Denise J Jamieson; Irma Rodriguez; Kenneth H Mayer; Raymond T Chung
Journal:  J Infect Dis       Date:  2007-05-02       Impact factor: 5.226

9.  Molecular and bioinformatic evidence of hepatitis C virus evolution in brain.

Authors:  Sarah L Fishman; Jacinta M Murray; Francis J Eng; José L Walewski; Susan Morgello; Andrea D Branch
Journal:  J Infect Dis       Date:  2008-02-15       Impact factor: 5.226

10.  Genetic characterization of hepatitis B virus in peripheral blood leukocytes: evidence for selection and compartmentalization of viral variants with the immune escape G145R mutation.

Authors:  Sibnarayan Datta; Rajesh Panigrahi; Avik Biswas; Partha K Chandra; Arup Banerjee; Pradip K Mahapatra; Chinmoy K Panda; Shekhar Chakrabarti; Sujit K Bhattacharya; Kuntal Biswas; Runu Chakravarty
Journal:  J Virol       Date:  2009-05-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.